ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
Erickson PF, Dessev G, Lasher RS, Philips G, Robinson M, Drabkin HA. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease. Blood. 1996 Sep 01; 88(5):1813-23.
-
Acute Disease
-
Animals
-
Antigens, CD34
-
Biomarkers, Tumor
-
Bone Marrow
-
Bone Marrow Cells
-
Burkitt Lymphoma
-
Cell Transformation, Neoplastic
-
Chromosomes, Human, Pair 21
-
Chromosomes, Human, Pair 8
-
Core Binding Factor Alpha 2 Subunit
-
DNA-Binding Proteins
-
Gene Expression Regulation, Leukemic
-
Hematopoietic Stem Cells
-
HL-60 Cells
-
Humans
-
Immune Sera
-
Leukemia, Erythroblastic, Acute
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Leukemia, Myeloid
-
Neoplasm Proteins
-
Neoplasm, Residual
-
Oncogene Proteins, Fusion
-
Peptide Fragments
-
Phosphorylation
-
Protein Processing, Post-Translational
-
Proto-Oncogene Proteins
-
Rabbits
-
RUNX1 Translocation Partner 1 Protein
-
Transcription Factors
-
Translocation, Genetic
-
Tumor Cells, Cultured